Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2015-12-21 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2015-12-21 English
FORM 8-K
Governance Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 18, 2015, reporting an amendment and restatement of the company's Bylaws to implement a proxy access provision. The content focuses on changes to the corporate governance documents (Bylaws) and includes the amended Bylaws as an exhibit. There is no financial data, earnings information, or other report types such as annual or quarterly reports. The primary subject is governance-related changes to the company's internal rules and board nomination procedures. Therefore, the document fits best under Governance Information (CGR). The document length is 3363 characters, which is short but contains substantive governance content, not just an announcement or certification. Hence, it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2015-12-18 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically describes an amendment to a credit facility agreement, which is a financing activity. There are no financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. The document focuses on a material definitive agreement related to credit facilities, which fits the Capital/Financing Update category. The document length is 3427 characters, which is short but contains substantive information about the financing amendment, not just an announcement of a report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-12-09 English
PRIMARY DOCUMENT
Director's Dealing
2015-12-08 English
PRIMARY DOCUMENT
Director's Dealing
2015-12-04 English
PRIMARY DOCUMENT
Director's Dealing
2015-11-24 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.